You are here:
Tamoxifen: Interaction with CYP2D6 inhibitors
2010.11.04
Active substance: tamoxifen
Concomitant administration of tamoxifen and strong inhibitors of the cytochrome P450 2D6 enzyme (CYP2D6) should be avoided, as a resulting reduced efficacy of tamoxifen cannot be excluded.
risk information - full text (available in German only)